{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:08:12Z","timestamp":1768417692753,"version":"3.49.0"},"reference-count":65,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Compagnia di San Paolo"},{"name":"University of Turin"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Poor prognosis in high-grade gliomas is mainly due to fatal relapse after surgical resection in the absence of efficient chemotherapy, which is severely hampered by the blood\u2013brain barrier. However, the leaky blood\u2013brain\u2013tumour barrier forms upon tumour growth and vascularization, allowing targeted nanocarrier-mediated drug delivery. The homotypic targeting ability of cell-membrane fragments obtained from cancer cells means that these fragments can be exploited to this aim. In this experimental work, injectable nanoemulsions, which have a long history of safe clinic usage, have been wrapped in glioma-cell membrane fragments via co-extrusion to give targeted, homogeneously sized, sterile formulations. These systems were then loaded with three different chemotherapeutics, in the form of hydrophobic ion pairs that can be released into the target site thanks to interactions with physiological components. The numerous assays performed in two-dimensional (2D) and three-dimensional (3D) cell models demonstrate that the proposed approach is a versatile drug-delivery platform with chemo-tactic properties towards glioma cells, with adhesive interactions between the target cell and the cell membrane fragments most likely being responsible for the effect. This approach\u2019s promising translational perspectives towards personalized nanomedicine mean that further in vivo studies are foreseen for the future.<\/jats:p>","DOI":"10.3390\/cells13070641","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T12:01:22Z","timestamp":1712577682000},"page":"641","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-3183","authenticated-orcid":false,"given":"Chiara","family":"Dianzani","sequence":"first","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Bozza","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1219-2949","authenticated-orcid":false,"given":"Valentina","family":"Bordano","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Cangemi","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Ferraris","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7784-3629","authenticated-orcid":false,"given":"Federica","family":"Foglietta","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-4168","authenticated-orcid":false,"given":"Chiara","family":"Monge","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Gallicchio","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6937-8632","authenticated-orcid":false,"given":"Stefania","family":"Pizzimenti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Corso Raffaello 30, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-5219","authenticated-orcid":false,"given":"Elisabetta","family":"Marini","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-6667","authenticated-orcid":false,"given":"Elisabetta","family":"Muntoni","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmen","family":"Valsania","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Turin, Via Quarello 15\/a, 10135 Turin, Italy"},{"name":"Nanostructured Interfaces and Surfaces (NIS) Interdepartmental Centre, University of Turin, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5081-3638","authenticated-orcid":false,"given":"Luigi","family":"Battaglia","sequence":"additional","affiliation":[{"name":"Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10124 Turin, Italy"},{"name":"Nanostructured Interfaces and Surfaces (NIS) Interdepartmental Centre, University of Turin, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/IJN.S231479","article-title":"Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours","volume":"15","author":"Ferraris","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2010.04.015","article-title":"Experimental approaches for the treatment of malignant gliomas","volume":"128","author":"Arko","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1054\/bjoc.2000.1459","article-title":"High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours","volume":"83","author":"Koukourakis","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/14737175.2.5.609","article-title":"Advances in the therapy of high-grade glioma at relapse: Pegylated liposomal doxorubicin","volume":"2","author":"Hau","year":"2002","journal-title":"Expert. Rev. Neurother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COC.0000000000000780","article-title":"Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial","volume":"44","author":"Elinzano","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1208\/s12249-010-9526-5","article-title":"Injectable lipid emulsions-advancements, opportunities and challenges","volume":"11","author":"Hippalgaonkar","year":"2010","journal-title":"AAPS PharmSciTech."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103321","DOI":"10.1016\/j.drudis.2022.07.006","article-title":"Repurposing of parenterally administered active substances used to treat pain both systemically and locally","volume":"27","author":"Battaglia","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.1412420111","article-title":"Clearance of pathological antibodies using biomimetic nanoparticles","volume":"111","author":"Copp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1039\/C4TB00980K","article-title":"Structural elucidation of cell membrane-derived nanoparticles using molecular probes","volume":"2","author":"Fan","year":"2014","journal-title":"J. Mater. Chem. B."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Harris, J.C., Scully, M.A., and Day, E.S. (2019). Cancer Cell Membrane-Coated Nanoparticles for Cancer Management. Cancers, 11.","DOI":"10.3390\/cancers11121836"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Li, H., Jin, K., Luo, M., Wang, X., Zhu, X., Liu, X., Jiang, T., Zhang, Q., Wang, S., and Pang, Z. (2019). Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles. Cells, 8.","DOI":"10.3390\/cells8080881"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"eaay9035","DOI":"10.1126\/sciadv.aay9035","article-title":"Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal","volume":"6","author":"Meyer","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_16","first-page":"879","article-title":"Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy","volume":"3","author":"Yaman","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Foglietta, F., Bozza, A., Ferraris, C., Cangemi, L., Bordano, V., Serpe, L., Martina, K., Lazzarato, L., Pizzimenti, S., and Grattarola, M. (2023). Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051358"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/nnm-2016-0380","article-title":"Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: Preliminary study for glioma treatment","volume":"12","author":"Battaglia","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_19","first-page":"147","article-title":"Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation","volume":"67","author":"Biasibetti","year":"2017","journal-title":"Comp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cyto.990210208","article-title":"Cell membrane labeling with fluorescent dyes for the demonstration of cytokine-induced fusion between monocytes and tumor cells","volume":"21","author":"Sarti","year":"1995","journal-title":"Cytometry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jps.24002","article-title":"Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: Preliminary in vitro studies","volume":"103","author":"Battaglia","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2016.08.018","article-title":"Development of polymeric irinotecan nanoparticles using a novel lactone preservation strategy","volume":"512","author":"Poudel","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00280-004-0840-z","article-title":"Improved potency of cisplatin by hydrophobic ion pairing","volume":"54","author":"Feng","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ajhp\/59.6.539","article-title":"Stability of irinotecan hydrochloride in aqueous solutions","volume":"59","author":"Li","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1081\/DDC-100101250","article-title":"Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. II. A high-performance liquid chromatographic method","volume":"26","author":"Raghavan","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1773-2247(10)50057-1","article-title":"Cisplatin-loaded SLN produced by coacervation technique","volume":"20","author":"Gallarate","year":"2010","journal-title":"J. Drug Del. Sci. Technol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dianzani, C., Monge, C., Miglio, G., Serpe, L., Martina, K., Cangemi, L., Ferraris, C., Mioletti, S., Osella, S., and Gigliotti, C.L. (2020). Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment. Cancers, 12.","DOI":"10.3390\/cancers12051198"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Monge, C., Stoppa, I., Ferraris, C., Bozza, A., Battaglia, L., Cangemi, L., Miglio, G., Pizzimenti, S., Clemente, N., and Gigliotti, C.L. (2022). Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment. Nanomaterials, 12.","DOI":"10.3390\/nano12234233"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1039\/C9NA00308H","article-title":"Hydrophobic ion pairing: Encapsulating small molecules, peptides, and proteins into nanocarriers","volume":"1","author":"Ristroph","year":"2019","journal-title":"Nanoscale Adv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3835(02)00085-X","article-title":"Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors","volume":"183","author":"Howng","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jnci\/djr224","article-title":"Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion","volume":"103","author":"Edwards","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41556-021-00639-4","article-title":"Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling","volume":"23","author":"Gao","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1091\/mbc.e06-03-0190","article-title":"Endocytosis of cadherin from intracellular junctions is the driving force for cadherin adhesive dimer disassembly","volume":"17","author":"Troyanovsky","year":"2006","journal-title":"Mol. Biol. Cell."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejcb.2004.12.009","article-title":"Cadherin dimers in cell-cell adhesion","volume":"84","author":"Troyanovsky","year":"2005","journal-title":"Eur. J. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: A new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0022-2836(77)90227-3","article-title":"Cross-link repair in human cells and its possible defect in Fanconi\u2019s anemia cells","volume":"113","author":"Fujiwara","year":"1977","journal-title":"J. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1073\/pnas.85.12.4158","article-title":"The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove","volume":"85","author":"Rice","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuro.2008.02.010","article-title":"Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity","volume":"29","author":"Fischer","year":"2008","journal-title":"Neurotoxicology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<491::AID-IJC10>3.0.CO;2-M","article-title":"pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells","volume":"83","author":"Kobayashi","year":"1999","journal-title":"Int. J. Cancer."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00280-001-0393-3","article-title":"Factors influencing the cellular accumulation of SN-38 and camptothecin","volume":"49","author":"Cummings","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13361-014-1071-0","article-title":"Quantitative determination of irinotecan and the metabolite SN-38 by nanoflow liquid chromatography-tandem mass spectrometry in different regions of multicellular tumor spheroids","volume":"26","author":"Liu","year":"2015","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2016.04.027","article-title":"Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines","volume":"506","author":"Najlah","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2203120","DOI":"10.1002\/adhm.202203120","article-title":"A Novel Patient-Personalized Nanovector Based on Homotypic Recognition and Magnetic Hyperthermia for an Efficient Treatment of Glioblastoma Multiforme","volume":"12","author":"Pucci","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(00)02889-4","article-title":"Intracerebroventricular propofol is neuroprotective against transient global ischemia in rats: Extracellular glutamate level is not a major determinant","volume":"883","author":"Yano","year":"2000","journal-title":"Brain Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12630-008-9031-4","article-title":"The potential use of intralipid to minimize propofol\u2019s cardiovascular effects","volume":"56","author":"Gragasin","year":"2009","journal-title":"Can. J. Anesth."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ALN.0b013e31825ad8de","article-title":"Lipid emulsion infusion: Resuscitation for local anesthetic and other drug overdose","volume":"117","author":"Weinberg","year":"2012","journal-title":"Anesthesiology"},{"key":"ref_47","first-page":"1","article-title":"Mechanisms and Efficacy of Intravenous Lipid Emulsion Treatment for Systemic Toxicity From Local Anesthetics","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Di Pietro, S., Falcone, A., Arfuso, F., Pennisi, M., Piccione, G., and Giudice, E. (2022). Treatment of Permethrin Toxicosis in Cats by Intravenous Lipid Emulsion. Toxics, 10.","DOI":"10.3390\/toxics10040165"},{"key":"ref_49","first-page":"596","article-title":"Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences","volume":"31","author":"Dao","year":"2016","journal-title":"Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Enter. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-019-1627-x","article-title":"Cerebrospinal fluid lipidomics: Effects of an intravenous triglyceride infusion and apoE status","volume":"16","author":"Hanson","year":"2020","journal-title":"Metabolomics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/CMI.1000139","article-title":"Intralipid treatment for Alzheimer Disease","volume":"2","author":"Eldor","year":"2017","journal-title":"Clin. Med. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Muntoni, E., Marini, E., Ferraris, C., Garelli, S., Capucchio, M.T., Colombino, E., Panciani, P.P., and Battaglia, L. (2022). Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations. Colloids Surf. B. Biointerfaces, 214.","DOI":"10.1016\/j.colsurfb.2022.112470"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/2.1.45","article-title":"The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery","volume":"2","author":"Groothuis","year":"2000","journal-title":"Neuro Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/17425247.2012.682726","article-title":"Recent advances in brain tumor-targeted nano-drug delivery systems","volume":"9","author":"Liu","year":"2012","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hoarau-V\u00e9chot, J., Rafii, A., Touboul, C., and Pasquier, J. (2018). Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010181"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.R., Rehnmark, S., Verbeke, C., Toftg\u00e5rd, R., L\u00f6hr, M., and Heuchel, R.L. (2013). 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-95"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"35367","DOI":"10.1038\/srep35367","article-title":"Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model","volume":"6","author":"Cavo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Vitale, C., Marzagalli, M., Scaglione, S., Dondero, A., Bottino, C., and Castriconi, R. (2022). Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies. Cancers, 14.","DOI":"10.3390\/cancers14041013"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Dai, X., Ma, C., Lan, Q., and Xu, T. (2016). 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Biofabrication, 8.","DOI":"10.1088\/1758-5090\/8\/4\/045005"},{"key":"ref_60","unstructured":"Rehm, B., and Moradali, M. Alginates and Their Biomedical Applications, Springer."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3389\/fimmu.2019.01876","article-title":"Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies","volume":"10","author":"Marrella","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-0716-2703-7_16","article-title":"3D Human Tumor Tissues Cultured in Dynamic Conditions as Alternative In Vitro Disease Models","volume":"2572","author":"Pelizzoni","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Trujillo-de Santiago, G., Flores-Garza, B.G., Tavares-Negrete, J.A., Lara-Mayorga, I.M., Gonz\u00e1lez-Gamboa, I., Zhang, Y.S., Rojas-Mart\u00ednez, A., Ortiz-L\u00f3pez, R., and \u00c1lvarez, M.M. (2019). The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors. Materials, 12.","DOI":"10.3390\/ma12182945"},{"key":"ref_64","first-page":"82","article-title":"3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay","volume":"38","author":"Marrella","year":"2021","journal-title":"ALTEX"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Marzagalli, M., Pelizzoni, G., Fedi, A., Vitale, C., Fontana, F., Bruno, S., Poggi, A., Dondero, A., Aiello, M., and Castriconi, R. (2022). A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.945149"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/7\/641\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:24:06Z","timestamp":1760106246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/7\/641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,6]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["cells13070641"],"URL":"https:\/\/doi.org\/10.3390\/cells13070641","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,6]]}}}